Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 11
2007 13
2008 12
2009 9
2010 7
2011 7
2012 11
2013 8
2014 7
2015 11
2016 12
2017 6
2018 3
2019 3
2020 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Novel options for the treatment of castration-resistant prostate cancer.
Ohlmann CH, Merseburger AS, Suttmann H, Schilling D, Trojan L, Kempkensteffen C, Corvin S, Mathers MJ, Bastian PJ. Ohlmann CH, et al. Among authors: kempkensteffen c. World J Urol. 2012 Aug;30(4):495-503. doi: 10.1007/s00345-011-0796-7. Epub 2011 Nov 20. World J Urol. 2012. PMID: 22101903 Review.
Dynamics of Urinary Calprotectin after Renal Ischaemia.
Ebbing J, Seibert FS, Pagonas N, Bauer F, Miller K, Kempkensteffen C, Günzel K, Bachmann A, Seifert HH, Rentsch CA, Ardelt P, Wetterauer C, Amico P, Babel N, Westhoff TH. Ebbing J, et al. Among authors: kempkensteffen c. PLoS One. 2016 Jan 8;11(1):e0146395. doi: 10.1371/journal.pone.0146395. eCollection 2016. PLoS One. 2016. PMID: 26745147 Free PMC article.
Serum and tissue syndecan-1 levels in renal cell carcinoma.
Niedworok C, Kempkensteffen C, Eisenhardt A, Tschirdewahn S, Rehme C, Panic A, Reis H, Baba H, Nyirády P, Hadaschik B, Kovalszky I, Szarvas T. Niedworok C, et al. Among authors: kempkensteffen c. Transl Androl Urol. 2020 Jun;9(3):1167-1176. doi: 10.21037/tau-19-787. Transl Androl Urol. 2020. PMID: 32676400 Free PMC article.
Intermittent vs continuous docetaxel therapy in patients with metastatic castration-resistant prostate cancer - a phase III study (PRINCE).
Cash H, Steiner U, Heidenreich A, Klotz T, Albers P, Melchior S, Martus P, Fuller F, Magheli A, Hinz S, Kempkensteffen C, Miller K; PRINCE investigators. Cash H, et al. Among authors: kempkensteffen c. BJU Int. 2018 Nov;122(5):774-782. doi: 10.1111/bju.14239. Epub 2018 May 6. BJU Int. 2018. PMID: 29633515 Clinical Trial.
95 results